摘要
背景:越来越多的证据表明,未能从积极的语义干扰(Frpsi)的影响中恢复,代表了临床前阿尔茨海默症的早期认知表现。疾病。这一新范式的一个限制是,只关注正确回忆的目标数量,而不检查可能突出显示特定内容的共现语义入侵[si]。内存中的IC故障。 目的:研究遗忘性轻度认知障碍(AMCI)患者的SI及其与淀粉样蛋白负荷和局部皮质厚度的关系。 方法:对33例确诊为aMCI的老年人行F-18脑淀粉样蛋白PET扫描和MRI脑扫描。在LO的线索回忆试验中,我们测量了SI的相关性。文斯泰因-Acevedo量表用于AD易发地区平均皮质淀粉样蛋白负荷和区域皮质厚度的语义干扰和学习[LASI-L]。 结果:SI对FRPSI敏感的措施与更大的总淀粉样负荷和较低的总体皮质厚度有关。 特别是,Si与左E中的降低的Cth高度相关。ntorhinal皮质[r=-.71;p<.001]和左侧眶内侧额叶[r=-.64;p<.001],共占回归模型解释变异的66%。 结论。语义侵犯易受fpsi影响的测量与脑淀粉样蛋白负荷增加和皮质厚度降低有关。这些发现进一步支持了ffpsi,as expres的假设。SED可作为早期神经变性的认知标志,可作为临床前AD的早期鉴别检查,可用于初级保健或cli。审判现场。
关键词: 语义侵犯,阿尔茨海默氏症,MCI,淀粉样蛋白显像,临床前,轻度认知障碍。
Current Alzheimer Research
Title:Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness
Volume: 15 Issue: 9
关键词: 语义侵犯,阿尔茨海默氏症,MCI,淀粉样蛋白显像,临床前,轻度认知障碍。
摘要: Background: Accumulating evidence indicates that the failure to recover from the effects of proactive semantic interference [frPSI] represents an early cognitive manifestation of preclinical Alzheimer's disease. A limitation of this novel paradigm has been a singular focus on the number of targets correctly recalled, without examining co-occurring semantic intrusions [SI] that may highlight specific breakdowns in memory.
Objectives: We focused on SI and their relationship to amyloid load and regional cortical thickness among persons with amnestic mild cognitive impairment (aMCI).
Methods: Thirty-three elders diagnosed with aMCI underwent F-18 florbetaben amyloid PET scanning with MRI scans of the brain. We measured the correlation of SI elicited on cued recall trials of the Loewenstein-Acevedo Scales for Semantic Interference and Learning [LASSI-L] with mean cortical amyloid load and regional cortical thickness in AD prone regions.
Results: SI on measures sensitive to frPSI was related to greater total amyloid load and lower overall cortical thickness [CTh]. In particular, SI were highly associated with reduced CTh in the left entorhinal cortex [r=-.71; p<.001] and left medial orbital frontal lobe [r=-.64; p<.001]; together accounting for 66% of the explained variability in regression models.
Conclusion. Semantic intrusions on measures susceptible to frPSI related to greater brain amyloid load and lower cortical thickness. These findings further support the hypothesis that frPSI, as expressed by the percentage of intrusions, may be a cognitive marker of initial neurodegeneration and may serve as an early and distinguishing test for preclinical AD that may be used in primary care or clinical trial settings.
Export Options
About this article
Cite this article as:
Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness, Current Alzheimer Research 2018; 15 (9) . https://dx.doi.org/10.2174/1567205015666180427122746
DOI https://dx.doi.org/10.2174/1567205015666180427122746 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology (Commentary [Research Highlights] A Toll Road to Alzheimer Disease?)
CNS & Neurological Disorders - Drug Targets Smoking and Hypertension: Effects on Clinical, Biochemical and Pathological Variables Due to Isolated or Combined Action on Cardiovascular System
Current Pharmaceutical Design Smoking and Hypertension: Independent or Additive Effects to Determining Vascular Damage?
Current Vascular Pharmacology Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
Current Neurovascular Research Accurate and Unbiased Quantitation of Amyloid-β Fluorescence Images Using ImageSURF
Current Alzheimer Research Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology Prevalence of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimers Disease, and its Relationship with Cognitive Impairment
Current Alzheimer Research Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science Blue-Enriched Lighting for Older People Living in Care Homes: Effect on Activity, Actigraphic Sleep, Mood and Alertness
Current Alzheimer Research Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
Current Medicinal Chemistry Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Central Nervous System Acting Drugs in Treatment of Migraine Headache
Central Nervous System Agents in Medicinal Chemistry Stem Cell Function, Self-Renewal, Heterogeneity, and Regenerative Potential in Skeletal Muscle Stem Cells
Recent Patents on Regenerative Medicine Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology
Current Alzheimer Research Cannabinoids and Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Cognition-Enhancing Drugs in Mild Cognitive Impairment (MCI) and Alzheimers Disease (AD): An Update [1]
Medicinal Chemistry Reviews - Online (Discontinued)